Planarians in pharmacology: parthenolide is a specific behavioral antagonist of cocaine in the planarian Girardia tigrina.

Oné R Pagán's picture
PDF versionPDF version
TitlePlanarians in pharmacology: parthenolide is a specific behavioral antagonist of cocaine in the planarian Girardia tigrina.
Publication TypeJournal Article
Year of Publication2012
AuthorsPagán, OR, Baker, D, Deats, S, Montgomery, E, Tenaglia, M, Randolph, C, Kotturu, D, Tallarida, C, Bach, D, Wilk, G, Rawls, S, Raffa, RB
JournalInt J Dev Biol
Volume56
Issue1-3
Pagination193-6
Date Published2012
ISSN1696-3547
KeywordsAnimals, Anti-Inflammatory Agents, Non-Steroidal, Behavior, Animal, Cocaine, Dopamine Uptake Inhibitors, Excitatory Amino Acid Agonists, Methamphetamine, N-Methylaspartate, Nicotine, Nicotinic Agonists, Planarians, Regeneration, Seizures, Sesquiterpenes
Abstract

Planarians are traditional animal models in developmental and regeneration biology. Recently, these organisms are arising as vertebrate-relevant animal models in neuropharmacology. Using an adaptation of published behavioral protocols, we have described the alleviation of cocaine-induced planarian seizure-like movements (pSLM) by a naturally-occurring sesquiterpene lactone, parthenolide. Interestingly, parthenolide does not prevent the expression of pSLM induced by amphetamines; in vertebrates, amphetamines interact with the same protein target as cocaine. Parthenolide is also unable to prevent pSLM elicited by the cholinergic com-pounds nicotine and cytisine or by the glutamatergic agents L- or D- glutamic acid or NMDA. Thus, we conclude that parthenolide is a specific anti-cocaine agent in this experimental organism.

DOI10.1387/ijdb.113486op
Alternate JournalInt. J. Dev. Biol.
PubMed ID22451007
Grant ListR01-DA15378 / DA / NIDA NIH HHS / United States
R03-DA026518 / DA / NIDA NIH HHS / United States